Observational study / 2006
Coffee intake was linked to higher nonfatal myocardial infarction risk only among individuals who were slow caffeine metabolizers.
A case-control study assessed whether CYP1A2 genotype modified the link between caffeinated coffee consumption and first acute nonfatal myocardial infarction (MI) in Costa Rica. Among carriers of the slow *1F allele, multivariate-adjusted ORs (95% CIs) for nonfatal MI across <1, 1, 2-3, and >=4 cups of coffee per day were 1.00 (reference), 0.99 (0.69-1.44), 1.36 (1.01-1.83), and 1.64 (1.14-2.34). In contrast, corresponding ORs for rapid *1A/*1A individuals were 1.00, 0.75 (0.51-1.12), 0.78 (0.56-1.09), and 0.99 (0.66-1.48) (P = .04 for interaction). Among participants younger than 59 years, >=4 cups/day had an OR of 2.33 (1.39-3.89) in slow metabolizers, whereas rapid metabolizers had lower risks with 1 and 2-3 cups/day.
Shows an association, not proof of cause and effect.
- Study type
- Case-control study
- Who was studied
- 2,014 cases with first acute nonfatal MI and 2,014 matched population controls in Costa Rica
- What was measured
- Relative risk of nonfatal myocardial infarction associated with coffee intake
THE PAPER
Coffee, CYP1A2 genotype, and risk of myocardial infarction.
Cornelis MC, El-Sohemy A, Kabagambe EK, Campos H. JAMA, 2006.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.